NRx Pharmaceuticals, Inc. (NRXP) Misses Q1 EPS by 2c

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
• Capitol Federal Financial names William Skrobacz Jr. as president